Skip to main content
HCAT
NASDAQ Technology

Health Catalyst Closes $147M Vitalware Sale, Pays Off All Debt

Tom Rudovsky · Reported by PR Newswire
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.86
Mkt Cap
$170.695M
52W Low
$0.955
52W High
$3.88
52W Position info
95% above low
Off High info
52% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

HCAT sits 95% above its 52-week low of $0.955.

Summary

Health Catalyst completed the $147 million sale of its Vitalware unit, using the proceeds plus cash on hand to fully repay its credit facility. The debt elimination removes roughly $19 million in annual interest expense, strengthening the balance sheet after a Q1 that included a $111 million net loss and a $95.5 million goodwill impairment. The company is now debt-free and plans to focus investment on its core healthcare intelligence platform. This follows the June 4 divestiture announcement and the July 17 shareholder vote against board declassification.

Updates

  1. · SEC 8-K — Q2 revenue was $70.5 million, net loss $40.5 million, adjusted EBITDA $9.9 million. Q3 guidance: revenue $55-56 million, adjusted EBITDA $0-0.5 million. Full-year guidance: revenue $246-249 million, adjusted EBITDA $18-18.5 million.

At the time of this announcement, HCAT was trading at $1.86 on NASDAQ in the Technology sector, with a market capitalization of approximately $170.7M. The 52-week trading range was $0.96 to $3.88. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

HCAT - Latest Insights

HCAT
Nov 05, 2026, 5:17 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.50
Real-time Price: $1.31 info
Change: -$0.190 (-13%) info
Market Cap: $99.764M info
HCAT
Nov 05, 2026, 4:03 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.50
Real-time Price: $1.31 info
Change: -$0.190 (-13%) info
Market Cap: $99.764M info
HCAT
Sep 08, 2026, 5:04 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $1.70
Real-time Price: $1.31 info
Change: -$0.390 (-23%) info
Market Cap: $99.764M info
HCAT
Sep 08, 2026, 8:13 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.63
Real-time Price: $1.31 info
Change: -$0.320 (-20%) info
Market Cap: $99.764M info
HCAT
Aug 06, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.67
Real-time Price: $1.31 info
Change: -$0.360 (-22%) info
Market Cap: $99.764M info